Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer

PURPOSE: The Trial Assigning Individualized Options for Treatment (TAILORx) found chemotherapy could be omitted in many women with hormone receptor–positive, HER2-negative, node-negative breast cancer and 21-gene recurrence scores (RS) 11–25, but left unanswered questions. We used simulation modelin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayasekera, Jinani, Sparano, Joseph A, Gray, Robert, Isaacs, Claudine, Kurian, Allison, O’Neill, Suzanne, Schechter, Clyde B, Mandelblatt, Jeanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049983/
https://www.ncbi.nlm.nih.gov/pubmed/32337487
http://dx.doi.org/10.1093/jncics/pkz062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049983/
https://www.ncbi.nlm.nih.gov/pubmed/32337487
http://dx.doi.org/10.1093/jncics/pkz062

Ejemplares similares